Physician

Nikhil Shashikant Joshi, MD

According to 2025 Medicare claims, Nikhil Joshi, MD (NPI: 1437253481) practices cardiology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is NORTH TEXAS COMPREHENSIVE CARDIOLOGY, PLLC (NPI: 1902266208; TIN: 811453555) and primary practice location at 75090-0504.

Joshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,128 traditional Medicare patients, billed 20,480 HCPCS/CPT codes, and received $1,824,379 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 13,381 prescription claims across 1,328 beneficiaries totaling $1,751,647 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 11 claims. Open Payments data shows 88 records totaling $471,314. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $568,831 to $1,824,379. Similarly, Part D prescription costs have moved sharply higher in recent years, from $436,884 to $1,751,647. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,561	8,942	$568,831
2016	1,620	10,856	$660,290
2017	1,388	11,331	$944,236
2018	1,293	13,320	$1,359,959
2019	1,000	11,346	$1,367,968
2020	1,046	12,684	$1,436,998
2021	1,148	11,486	$1,186,475
2022	928	9,735	$1,108,980
2023	968	10,017	$1,095,524
2024	1,128	20,480	$1,824,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	681	8,087	$436,884
2016	764	9,537	$628,828
2017	814	9,475	$686,797
2018	898	10,829	$814,139
2019	959	11,435	$950,453
2020	1,030	11,882	$1,174,810
2021	1,132	12,181	$1,468,817
2022	1,170	12,164	$1,615,077
2023	1,167	12,076	$1,798,655
2024	1,328	13,381	$1,751,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	19	19	$1,526
2017	11	11	$889
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	356	359	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	770	1,906	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	691	1,180	$61
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	278	296	$48
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	582	689	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	823	37,830	$721,339
Entresto	Sacubitril/Valsartan	318	12,759	$269,363
Xarelto	Rivaroxaban	320	14,099	$256,033
Repatha Sureclick	Evolocumab	100	4,012	$78,777
Farxiga	Dapagliflozin Propanediol	100	4,056	$73,249

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$1,855	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$469,459	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nikhil Shashikant Joshi, MD?

Tedicare shows public-source Medicare data for Nikhil Shashikant Joshi, MD (NPI 1437253481), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nikhil Shashikant Joshi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nikhil Shashikant Joshi, MD?

Nikhil Shashikant Joshi, MD is linked to NORTH TEXAS COMPREHENSIVE CARDIOLOGY, PLLC (billing NPI 1902266208) in the available physician profile data.

Does Nikhil Shashikant Joshi, MD have Open Payments data?

Nikhil Shashikant Joshi, MD has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.